文献速递复苏、休克与脓毒症呼吸衰竭与机械通气消化、代谢与肾脏急症

肺源性脓毒症与腹腔源性脓毒症的临床特征及死亡预测因素存在差异

CLINICAL CHARACTERISTICS AND PREDICTORS OF MORTALITY DIFFER BETWEEN PULMONARY AND ABDOMINAL SEPSIS.
PubMed 文献 · Shock · 2023-06-03
一句话结论肺源性脓毒症28天死亡率高于腹腔源性脓毒症,且两者死亡预测因素不同:肺源性为PaO2/FiO2比值与急性肾损伤,腹腔源性为SAPS II评分。

这项多中心回顾性研究纳入1359例符合Sepsis-3标准的成人脓毒症患者,分为肺源性脓毒症组(n=895)与腹腔源性脓毒症组(n=464),检测血浆presepsin并计算APACHE II、MEDS、SAPS II评分,收集28天死亡率。肺源性脓毒症组28天死亡率、病情严重程度评分、休克和急性肾损伤发生率及住院费用均高于腹腔源性脓毒症组。乳酸、APACHE II和MEDS评分在两种脓毒症中均与28天死亡率独立相关;肺源性脓毒症的独立预测因素包括PaO2/FiO2比值(HR 0.998;P<0.001)和急性肾损伤(HR 1.312;P=0.039),腹腔源性脓毒症为SAPS II评分(HR 1.037;P=0.017)。无休克患者中肺源性脓毒症死亡率高于腹腔源性脓毒症(32.9% vs. 8.8%;P<0.001),休克患者中两者无显著差异(63.7% vs. 48.4%;P=0.118)。

要点

  • 肺源性脓毒症(n=895)28天死亡率、病情严重程度评分、休克和急性肾损伤发生率及住院费用均高于腹腔源性脓毒症(n=464)。
  • 乳酸、APACHE II和MEDS评分在肺源性与腹腔源性脓毒症中均与28天死亡率独立相关。
  • 肺源性脓毒症的独立死亡预测因素为PaO2/FiO2比值(HR 0.998;P<0.001)和急性肾损伤(HR 1.312;P=0.039)。
  • 腹腔源性脓毒症的独立死亡预测因素为SAPS II评分(HR 1.037;P=0.017)。
  • 无休克患者中肺源性脓毒症死亡率高于腹腔源性脓毒症(32.9% vs. 8.8%;P<0.001),休克患者中两者无显著差异(63.7% vs. 48.4%;P=0.118)。

适用人群与场景

  • 符合Sepsis-3标准的成人脓毒症患者,共1359例,分为肺源性脓毒症组(n=895)和腹腔源性脓毒症组(n=464)。

诊断标准与关键阈值

  • 采用Sepsis-3标准诊断脓毒症。
  • 纳入时计算APACHE II、MEDS和SAPS II评分,并检测血浆presepsin。

研究设计与关键结果

  • 多中心回顾性研究,纳入1359例符合Sepsis-3标准的成人脓毒症患者,分为肺源性脓毒症组(n=895)和腹腔源性脓毒症组(n=464)。
  • 肺源性脓毒症组较腹腔源性脓毒症组28天死亡率更高,病情严重程度评分、休克和急性肾损伤发生率及住院费用均更高。
  • 乳酸、APACHE II和MEDS评分在两种脓毒症中均与28天死亡率独立相关。
  • 肺源性脓毒症的独立预测因素:PaO2/FiO2比值(HR 0.998;P<0.001)和急性肾损伤(HR 1.312;P=0.039)。
  • 腹腔源性脓毒症的独立预测因素:SAPS II评分(HR 1.037;P=0.017)。
  • 联合APACHE II评分、乳酸和MEDS评分或SAPS II评分的模型,分别在预测肺源性脓毒症或腹腔源性脓毒症患者死亡率时具有最佳受试者工作特征曲线下面积。
  • 交互项分析证实28天死亡率与乳酸、APACHE II评分、MEDS评分、SAPS II评分和休克的关联因脓毒症亚组而异。
  • 无休克患者中,肺源性脓毒症死亡率高于腹腔源性脓毒症(32.9% vs. 8.8%;P<0.001);休克患者中两者无显著差异(63.7% vs. 48.4%;P=0.118)。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,肺源性脓毒症与腹腔源性脓毒症具有不同的死亡预测因素,应据此进行亚组特异性风险评估。
  • 作者认为,休克对腹腔源性脓毒症患者死亡率的影响大于肺源性脓毒症患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Pulmonary sepsis and abdominal sepsis have pathophysiologically distinct phenotypes. This study aimed to compare their clinical characteristics and predictors of mortality. Methods: In this multicenter retrospective trial, 1,359 adult patients who fulfilled the Sepsis-3 criteria were enrolled and classified into the pulmonary sepsis or abdominal sepsis groups. Plasma presepsin was measured, and the scores of Acute Physiology and Chronic Health Evaluation (APACHE) II, Mortality in Emergency Department Sepsis (MEDS), and Simplified Acute Physiology Score (SAPS) II were calculated at enrollment. Data on 28-day mortality were collected for all patients. Results: Compared with patients with abdominal sepsis (n = 464), patients with pulmonary sepsis (n = 895) had higher 28-day mortality rate, illness severity scores, incidence of shock and acute kidney injury, and hospitalization costs. Lactate level and APACHE II and MEDS scores were independently associated with 28-day mortality in both sepsis types. Independent predictors of 28-day mortality included Pa o2 /F io2 ratio (hazard ratio [HR], 0.998; P < 0.001) and acute kidney injury (HR, 1.312; P = 0.039) in pulmonary sepsis, and SAPS II (HR, 1.037; P = 0.017) in abdominal sepsis. A model that combined APACHE II score, lactate, and MEDS score or SAPS II score had the best area under the receiver operating characteristic curve in predicting mortality in patients with pulmonary sepsis or abdominal sepsis, respectively. Interaction term analysis confirmed the association between 28-day mortality and lactate, APACHE II score, MEDS score, SAPS II score, and shock according to the sepsis subgroups. The mortality of patients with pulmonary sepsis was higher than that of patients with abdominal sepsis among patients without shock (32.9% vs. 8.8%; P < 0.001) but not among patients with shock (63.7 vs. 48.4%; P = 0.118). Conclusions: Patients with pulmonary sepsis had higher 28-day mortality than patients with abdominal sepsis. The study identified sepsis subgroup-specific mortality predictors. Shock had a larger effect on mortality in patients with abdominal sepsis than in those with pulmonary sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ren E, Xiao H, Li J, et al. CLINICAL CHARACTERISTICS AND PREDICTORS OF MORTALITY DIFFER BETWEEN PULMONARY AND ABDOMINAL SEPSIS. Shock. 2023. PMID: 37267265. doi:10.1097/SHK.0000000000002151

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。